Abbott has obtained CE mark approval for its Architect Stat high sensitive Troponin-I assay, designed for evaluating potential heart attacks sooner. The chemiluminescent microparticle immunoassay (CMIA), which is designed for use on ...
Tags: Abbott, CE mark, Architect Stat, potential heart attacks